Statin-associated exacerbation of myasthenia gravis.
Cartwright
Michael S
MS
Department of Neurology, Wake Forest University Baptist Medical Center, Winston-Salem, NC 27157, USA. mcartwri@wfubmc.edu
Jeffery
Douglas R
DR
Nuss
Geoffrey R
GR
Donofrio
Peter D
PD
D000069059:Atorvastatin; D016207:Cytokines / Q000096:biosynthesis / Q000378:metabolism; D004401:Dysarthria / Q000139:chemically induced*; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications; D008148:Lovastatin / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000187:drug effects; D008959:Models, Neurological; D009135:Muscular Diseases / Q000139:chemically induced; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D009431:Neural Conduction; D017035:Pravastatin / Q000009:adverse effects; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects*; D019821:Simvastatin / Q000009:adverse effects; D018418:Th2 Cells / Q000378:metabolism; D014451:Ubiquinone / Q000172:deficiency
D016207:Cytokines; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D014451:Ubiquinone; D008148:Lovastatin; D000069059:Atorvastatin; D019821:Simvastatin; D011729:Pyridostigmine Bromide; D017035:Pravastatin